Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithrombotic Agents Management”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Post-approval studies (Phase 4)Study completedNCT00178620
What this trial is testing

Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization

Who this might be right for
Heart DiseaseMyocardial InfarctionAcute Myocardial Infarction
The University of Texas Health Science Center, Houston 390
Post-approval studies (Phase 4)UnknownNCT03234114
What this trial is testing

Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

Who this might be right for
Acute Coronary Syndrome (ACS)Non-valvular Atrial Fibrillation (NVAF)
The First Affiliated Hospital with Nanjing Medical University 3,746
Not applicableStudy completedNCT04766606
What this trial is testing

Management of Anticoagulant Therapy in Non-cardiac Surgery.

Who this might be right for
Antithrombotic Agents Management
University of Ioannina 614
Not applicableStudy completedNCT02788344
What this trial is testing

Quality and Safety of Initial Management for ST-segment Elevation Myocardial Infarction

Who this might be right for
Myocardial Infarction
Centre Hospitalier Annecy Genevois 6,920
Large-scale testing (Phase 3)Looking for participantsNCT05892510
What this trial is testing

Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

Who this might be right for
Ischemic Stroke, AcuteCerebrovascular DisordersBrain Disorder+1 more
University of Melbourne 462
Large-scale testing (Phase 3)Ended earlyNCT00359424
What this trial is testing

Interventional Management of Stroke (IMS) III Trial

Who this might be right for
Stroke
Joseph Broderick 656
Not applicableLooking for participantsNCT06434324
What this trial is testing

Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion

Who this might be right for
Pleural Infection
Mayo Clinic 60
Testing effectiveness (Phase 2)WithdrawnNCT02150785
What this trial is testing

Asia Africa Streptokinase Trial

Who this might be right for
Ischemic Stroke
University of Alberta
Post-approval studies (Phase 4)Study completedNCT01955200
What this trial is testing

OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial

Who this might be right for
Coronary Artery Disease
The First Affiliated Hospital with Nanjing Medical University 1,724
Post-approval studies (Phase 4)Ended earlyNCT02945280
What this trial is testing

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

Who this might be right for
Deep Venous ThrombosisUpper Extremity Deep Venous ThrombosisThrombus+2 more
Intermountain Health Care, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00243906
What this trial is testing

Interventional Management of Stroke (IMS) II Study

Who this might be right for
Stroke
University of Cincinnati 81
Post-approval studies (Phase 4)UnknownNCT04116931
What this trial is testing

OPTImal Management of Antithrombotic Agents: OPTIMA-5

Who this might be right for
Acute Coronary Syndrome (ACS)
The First Affiliated Hospital with Nanjing Medical University 80
Not applicableUnknownNCT02921360
What this trial is testing

Early Administration of Aspirin in Patients With Acute Ischemic Stroke Treated With Systemic Thrombolysis

Who this might be right for
StrokeBrain Ischemia
City Clinical Hospital No. 67, Moscow, Russia 120
Testing effectiveness (Phase 2)Ended earlyNCT02227368
What this trial is testing

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Who this might be right for
Peripheral Artery Disease (PAD)
AstraZeneca 40